nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftazidime—Angiopathy—Pamidronate—osteoporosis	0.00219	0.00219	CcSEcCtD
Ceftazidime—Anaphylactic shock—Ibandronate—osteoporosis	0.00219	0.00219	CcSEcCtD
Ceftazidime—Immune system disorder—Pamidronate—osteoporosis	0.00218	0.00218	CcSEcCtD
Ceftazidime—Nervous system disorder—Raloxifene—osteoporosis	0.00217	0.00217	CcSEcCtD
Ceftazidime—Thrombocytopenia—Raloxifene—osteoporosis	0.00217	0.00217	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00216	0.00216	CcSEcCtD
Ceftazidime—Skin disorder—Raloxifene—osteoporosis	0.00215	0.00215	CcSEcCtD
Ceftazidime—Nervous system disorder—Ibandronate—osteoporosis	0.00215	0.00215	CcSEcCtD
Ceftazidime—Anaphylactic shock—Calcitriol—osteoporosis	0.00214	0.00214	CcSEcCtD
Ceftazidime—Skin disorder—Ibandronate—osteoporosis	0.00213	0.00213	CcSEcCtD
Ceftazidime—Nausea—Ergocalciferol—osteoporosis	0.00211	0.00211	CcSEcCtD
Ceftazidime—Urticaria—Etidronic acid—osteoporosis	0.0021	0.0021	CcSEcCtD
Ceftazidime—Bronchospasm—Estradiol—osteoporosis	0.00209	0.00209	CcSEcCtD
Ceftazidime—Abdominal pain—Etidronic acid—osteoporosis	0.00209	0.00209	CcSEcCtD
Ceftazidime—Skin disorder—Calcitriol—osteoporosis	0.00208	0.00208	CcSEcCtD
Ceftazidime—Angioedema—Ethinyl Estradiol—osteoporosis	0.00207	0.00207	CcSEcCtD
Ceftazidime—Dysgeusia—Pamidronate—osteoporosis	0.00206	0.00206	CcSEcCtD
Ceftazidime—Paraesthesia—Estropipate—osteoporosis	0.00205	0.00205	CcSEcCtD
Ceftazidime—Flushing—Zoledronate—osteoporosis	0.00205	0.00205	CcSEcCtD
Ceftazidime—Angioedema—Risedronate—osteoporosis	0.00202	0.00202	CcSEcCtD
Ceftazidime—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.00201	0.00201	CcSEcCtD
Ceftazidime—Angiopathy—Zoledronate—osteoporosis	0.002	0.002	CcSEcCtD
Ceftazidime—Immune system disorder—Zoledronate—osteoporosis	0.00199	0.00199	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Estropipate—osteoporosis	0.00197	0.00197	CcSEcCtD
Ceftazidime—Paraesthesia—Ibandronate—osteoporosis	0.00197	0.00197	CcSEcCtD
Ceftazidime—Pain—Estropipate—osteoporosis	0.00195	0.00195	CcSEcCtD
Ceftazidime—Hypersensitivity—Etidronic acid—osteoporosis	0.00195	0.00195	CcSEcCtD
Ceftazidime—Agitation—Pamidronate—osteoporosis	0.00193	0.00193	CcSEcCtD
Ceftazidime—Angiopathy—Conjugated Estrogens—osteoporosis	0.00193	0.00193	CcSEcCtD
Ceftazidime—Pain—Alendronate—osteoporosis	0.00192	0.00192	CcSEcCtD
Ceftazidime—Angioedema—Pamidronate—osteoporosis	0.00192	0.00192	CcSEcCtD
Ceftazidime—Immune system disorder—Conjugated Estrogens—osteoporosis	0.00192	0.00192	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.00192	0.00192	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00191	0.00191	CcSEcCtD
Ceftazidime—Infestation NOS—Estradiol—osteoporosis	0.00189	0.00189	CcSEcCtD
Ceftazidime—Infestation—Estradiol—osteoporosis	0.00189	0.00189	CcSEcCtD
Ceftazidime—Pain—Raloxifene—osteoporosis	0.00189	0.00189	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00189	0.00189	CcSEcCtD
Ceftazidime—Leukopenia—Pamidronate—osteoporosis	0.00188	0.00188	CcSEcCtD
Ceftazidime—Dysgeusia—Zoledronate—osteoporosis	0.00188	0.00188	CcSEcCtD
Ceftazidime—Pain—Ibandronate—osteoporosis	0.00187	0.00187	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00187	0.00187	CcSEcCtD
Ceftazidime—Pruritus—Etidronic acid—osteoporosis	0.00187	0.00187	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Estropipate—osteoporosis	0.00187	0.00187	CcSEcCtD
Ceftazidime—Jaundice—Estradiol—osteoporosis	0.00185	0.00185	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Alendronate—osteoporosis	0.00184	0.00184	CcSEcCtD
Ceftazidime—Pain—Calcitriol—osteoporosis	0.00183	0.00183	CcSEcCtD
Ceftazidime—Convulsion—Pamidronate—osteoporosis	0.00182	0.00182	CcSEcCtD
Ceftazidime—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00182	0.00182	CcSEcCtD
Ceftazidime—Urticaria—Estropipate—osteoporosis	0.00181	0.00181	CcSEcCtD
Ceftazidime—Dysgeusia—Conjugated Estrogens—osteoporosis	0.00181	0.00181	CcSEcCtD
Ceftazidime—Vision blurred—Zoledronate—osteoporosis	0.00181	0.00181	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Raloxifene—osteoporosis	0.00181	0.00181	CcSEcCtD
Ceftazidime—Diarrhoea—Etidronic acid—osteoporosis	0.00181	0.00181	CcSEcCtD
Ceftazidime—Abdominal pain—Estropipate—osteoporosis	0.00181	0.00181	CcSEcCtD
Ceftazidime—Body temperature increased—Estropipate—osteoporosis	0.00181	0.00181	CcSEcCtD
Ceftazidime—Tremor—Zoledronate—osteoporosis	0.0018	0.0018	CcSEcCtD
Ceftazidime—Skin disorder—Ethinyl Estradiol—osteoporosis	0.0018	0.0018	CcSEcCtD
Ceftazidime—Hepatobiliary disease—Estradiol—osteoporosis	0.00179	0.00179	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Ibandronate—osteoporosis	0.00179	0.00179	CcSEcCtD
Ceftazidime—Urticaria—Alendronate—osteoporosis	0.00179	0.00179	CcSEcCtD
Ceftazidime—Body temperature increased—Alendronate—osteoporosis	0.00178	0.00178	CcSEcCtD
Ceftazidime—Abdominal pain—Alendronate—osteoporosis	0.00178	0.00178	CcSEcCtD
Ceftazidime—Nervous system disorder—Risedronate—osteoporosis	0.00177	0.00177	CcSEcCtD
Ceftazidime—Agitation—Zoledronate—osteoporosis	0.00176	0.00176	CcSEcCtD
Ceftazidime—Angioedema—Zoledronate—osteoporosis	0.00175	0.00175	CcSEcCtD
Ceftazidime—Skin disorder—Risedronate—osteoporosis	0.00175	0.00175	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Calcitriol—osteoporosis	0.00175	0.00175	CcSEcCtD
Ceftazidime—Body temperature increased—Raloxifene—osteoporosis	0.00175	0.00175	CcSEcCtD
Ceftazidime—Abdominal pain—Raloxifene—osteoporosis	0.00175	0.00175	CcSEcCtD
Ceftazidime—Vision blurred—Conjugated Estrogens—osteoporosis	0.00174	0.00174	CcSEcCtD
Ceftazidime—Urticaria—Ibandronate—osteoporosis	0.00174	0.00174	CcSEcCtD
Ceftazidime—Abdominal pain—Ibandronate—osteoporosis	0.00173	0.00173	CcSEcCtD
Ceftazidime—Body temperature increased—Ibandronate—osteoporosis	0.00173	0.00173	CcSEcCtD
Ceftazidime—Leukopenia—Zoledronate—osteoporosis	0.00172	0.00172	CcSEcCtD
Ceftazidime—Anaphylactic shock—Pamidronate—osteoporosis	0.00172	0.00172	CcSEcCtD
Ceftazidime—Haemoglobin—Estradiol—osteoporosis	0.00171	0.00171	CcSEcCtD
Ceftazidime—Urticaria—Calcitriol—osteoporosis	0.0017	0.0017	CcSEcCtD
Ceftazidime—Haemorrhage—Estradiol—osteoporosis	0.0017	0.0017	CcSEcCtD
Ceftazidime—Abdominal pain—Calcitriol—osteoporosis	0.00169	0.00169	CcSEcCtD
Ceftazidime—Body temperature increased—Calcitriol—osteoporosis	0.00169	0.00169	CcSEcCtD
Ceftazidime—Angioedema—Conjugated Estrogens—osteoporosis	0.00169	0.00169	CcSEcCtD
Ceftazidime—Hypersensitivity—Estropipate—osteoporosis	0.00168	0.00168	CcSEcCtD
Ceftazidime—Nervous system disorder—Pamidronate—osteoporosis	0.00168	0.00168	CcSEcCtD
Ceftazidime—Thrombocytopenia—Pamidronate—osteoporosis	0.00168	0.00168	CcSEcCtD
Ceftazidime—Vomiting—Etidronic acid—osteoporosis	0.00168	0.00168	CcSEcCtD
Ceftazidime—Rash—Etidronic acid—osteoporosis	0.00166	0.00166	CcSEcCtD
Ceftazidime—Convulsion—Zoledronate—osteoporosis	0.00166	0.00166	CcSEcCtD
Ceftazidime—Dermatitis—Etidronic acid—osteoporosis	0.00166	0.00166	CcSEcCtD
Ceftazidime—Hypersensitivity—Alendronate—osteoporosis	0.00166	0.00166	CcSEcCtD
Ceftazidime—Headache—Etidronic acid—osteoporosis	0.00165	0.00165	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00162	0.00162	CcSEcCtD
Ceftazidime—Paraesthesia—Risedronate—osteoporosis	0.00162	0.00162	CcSEcCtD
Ceftazidime—Pruritus—Estropipate—osteoporosis	0.00162	0.00162	CcSEcCtD
Ceftazidime—Hypersensitivity—Ibandronate—osteoporosis	0.00161	0.00161	CcSEcCtD
Ceftazidime—Erythema multiforme—Estradiol—osteoporosis	0.00161	0.00161	CcSEcCtD
Ceftazidime—Hypotension—Pamidronate—osteoporosis	0.0016	0.0016	CcSEcCtD
Ceftazidime—Convulsion—Conjugated Estrogens—osteoporosis	0.0016	0.0016	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.0016	0.0016	CcSEcCtD
Ceftazidime—Pruritus—Alendronate—osteoporosis	0.00159	0.00159	CcSEcCtD
Ceftazidime—Hypersensitivity—Calcitriol—osteoporosis	0.00158	0.00158	CcSEcCtD
Ceftazidime—Flushing—Estradiol—osteoporosis	0.00158	0.00158	CcSEcCtD
Ceftazidime—Nausea—Etidronic acid—osteoporosis	0.00157	0.00157	CcSEcCtD
Ceftazidime—Anaphylactic shock—Zoledronate—osteoporosis	0.00157	0.00157	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00156	0.00156	CcSEcCtD
Ceftazidime—Diarrhoea—Estropipate—osteoporosis	0.00156	0.00156	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Risedronate—osteoporosis	0.00156	0.00156	CcSEcCtD
Ceftazidime—Pruritus—Ibandronate—osteoporosis	0.00155	0.00155	CcSEcCtD
Ceftazidime—Pain—Risedronate—osteoporosis	0.00154	0.00154	CcSEcCtD
Ceftazidime—Angiopathy—Estradiol—osteoporosis	0.00154	0.00154	CcSEcCtD
Ceftazidime—Paraesthesia—Pamidronate—osteoporosis	0.00154	0.00154	CcSEcCtD
Ceftazidime—Diarrhoea—Alendronate—osteoporosis	0.00154	0.00154	CcSEcCtD
Ceftazidime—Nervous system disorder—Zoledronate—osteoporosis	0.00154	0.00154	CcSEcCtD
Ceftazidime—Immune system disorder—Estradiol—osteoporosis	0.00154	0.00154	CcSEcCtD
Ceftazidime—Thrombocytopenia—Zoledronate—osteoporosis	0.00153	0.00153	CcSEcCtD
Ceftazidime—Skin disorder—Zoledronate—osteoporosis	0.00152	0.00152	CcSEcCtD
Ceftazidime—Pruritus—Calcitriol—osteoporosis	0.00152	0.00152	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00151	0.00151	CcSEcCtD
Ceftazidime—Diarrhoea—Raloxifene—osteoporosis	0.00151	0.00151	CcSEcCtD
Ceftazidime—Dizziness—Estropipate—osteoporosis	0.00151	0.00151	CcSEcCtD
Ceftazidime—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00151	0.00151	CcSEcCtD
Ceftazidime—Diarrhoea—Ibandronate—osteoporosis	0.0015	0.0015	CcSEcCtD
Ceftazidime—Dizziness—Alendronate—osteoporosis	0.00149	0.00149	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00148	0.00148	CcSEcCtD
Ceftazidime—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00148	0.00148	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Risedronate—osteoporosis	0.00148	0.00148	CcSEcCtD
Ceftazidime—Urticaria—Ethinyl Estradiol—osteoporosis	0.00147	0.00147	CcSEcCtD
Ceftazidime—Pain—Pamidronate—osteoporosis	0.00147	0.00147	CcSEcCtD
Ceftazidime—Diarrhoea—Calcitriol—osteoporosis	0.00147	0.00147	CcSEcCtD
Ceftazidime—Skin disorder—Conjugated Estrogens—osteoporosis	0.00147	0.00147	CcSEcCtD
Ceftazidime—Hypotension—Zoledronate—osteoporosis	0.00146	0.00146	CcSEcCtD
Ceftazidime—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00146	0.00146	CcSEcCtD
Ceftazidime—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00146	0.00146	CcSEcCtD
Ceftazidime—Dizziness—Raloxifene—osteoporosis	0.00146	0.00146	CcSEcCtD
Ceftazidime—Vomiting—Estropipate—osteoporosis	0.00145	0.00145	CcSEcCtD
Ceftazidime—Dysgeusia—Estradiol—osteoporosis	0.00145	0.00145	CcSEcCtD
Ceftazidime—Dizziness—Ibandronate—osteoporosis	0.00145	0.00145	CcSEcCtD
Ceftazidime—Rash—Estropipate—osteoporosis	0.00144	0.00144	CcSEcCtD
Ceftazidime—Dermatitis—Estropipate—osteoporosis	0.00144	0.00144	CcSEcCtD
Ceftazidime—Urticaria—Risedronate—osteoporosis	0.00143	0.00143	CcSEcCtD
Ceftazidime—Headache—Estropipate—osteoporosis	0.00143	0.00143	CcSEcCtD
Ceftazidime—Vomiting—Alendronate—osteoporosis	0.00143	0.00143	CcSEcCtD
Ceftazidime—Body temperature increased—Risedronate—osteoporosis	0.00143	0.00143	CcSEcCtD
Ceftazidime—Abdominal pain—Risedronate—osteoporosis	0.00143	0.00143	CcSEcCtD
Ceftazidime—Rash—Alendronate—osteoporosis	0.00142	0.00142	CcSEcCtD
Ceftazidime—Dermatitis—Alendronate—osteoporosis	0.00142	0.00142	CcSEcCtD
Ceftazidime—Hypotension—Conjugated Estrogens—osteoporosis	0.00141	0.00141	CcSEcCtD
Ceftazidime—Headache—Alendronate—osteoporosis	0.00141	0.00141	CcSEcCtD
Ceftazidime—Paraesthesia—Zoledronate—osteoporosis	0.00141	0.00141	CcSEcCtD
Ceftazidime—Vomiting—Raloxifene—osteoporosis	0.00141	0.00141	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Pamidronate—osteoporosis	0.0014	0.0014	CcSEcCtD
Ceftazidime—Rash—Raloxifene—osteoporosis	0.0014	0.0014	CcSEcCtD
Ceftazidime—Dermatitis—Raloxifene—osteoporosis	0.00139	0.00139	CcSEcCtD
Ceftazidime—Vomiting—Ibandronate—osteoporosis	0.00139	0.00139	CcSEcCtD
Ceftazidime—Tremor—Estradiol—osteoporosis	0.00139	0.00139	CcSEcCtD
Ceftazidime—Headache—Raloxifene—osteoporosis	0.00139	0.00139	CcSEcCtD
Ceftazidime—Rash—Ibandronate—osteoporosis	0.00138	0.00138	CcSEcCtD
Ceftazidime—Dermatitis—Ibandronate—osteoporosis	0.00138	0.00138	CcSEcCtD
Ceftazidime—Headache—Ibandronate—osteoporosis	0.00137	0.00137	CcSEcCtD
Ceftazidime—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00136	0.00136	CcSEcCtD
Ceftazidime—Vomiting—Calcitriol—osteoporosis	0.00136	0.00136	CcSEcCtD
Ceftazidime—Agitation—Estradiol—osteoporosis	0.00136	0.00136	CcSEcCtD
Ceftazidime—Nausea—Estropipate—osteoporosis	0.00136	0.00136	CcSEcCtD
Ceftazidime—Abdominal pain—Pamidronate—osteoporosis	0.00136	0.00136	CcSEcCtD
Ceftazidime—Body temperature increased—Pamidronate—osteoporosis	0.00136	0.00136	CcSEcCtD
Ceftazidime—Paraesthesia—Conjugated Estrogens—osteoporosis	0.00136	0.00136	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00135	0.00135	CcSEcCtD
Ceftazidime—Angioedema—Estradiol—osteoporosis	0.00135	0.00135	CcSEcCtD
Ceftazidime—Rash—Calcitriol—osteoporosis	0.00135	0.00135	CcSEcCtD
Ceftazidime—Dermatitis—Calcitriol—osteoporosis	0.00135	0.00135	CcSEcCtD
Ceftazidime—Headache—Calcitriol—osteoporosis	0.00134	0.00134	CcSEcCtD
Ceftazidime—Pain—Zoledronate—osteoporosis	0.00134	0.00134	CcSEcCtD
Ceftazidime—Nausea—Alendronate—osteoporosis	0.00134	0.00134	CcSEcCtD
Ceftazidime—Hypersensitivity—Risedronate—osteoporosis	0.00133	0.00133	CcSEcCtD
Ceftazidime—Nausea—Raloxifene—osteoporosis	0.00131	0.00131	CcSEcCtD
Ceftazidime—Pruritus—Ethinyl Estradiol—osteoporosis	0.00131	0.00131	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.0013	0.0013	CcSEcCtD
Ceftazidime—Nausea—Ibandronate—osteoporosis	0.0013	0.0013	CcSEcCtD
Ceftazidime—Pain—Conjugated Estrogens—osteoporosis	0.00129	0.00129	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Zoledronate—osteoporosis	0.00128	0.00128	CcSEcCtD
Ceftazidime—Pruritus—Risedronate—osteoporosis	0.00128	0.00128	CcSEcCtD
Ceftazidime—Nausea—Calcitriol—osteoporosis	0.00127	0.00127	CcSEcCtD
Ceftazidime—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00127	0.00127	CcSEcCtD
Ceftazidime—Hypersensitivity—Pamidronate—osteoporosis	0.00126	0.00126	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.00125	0.00125	CcSEcCtD
Ceftazidime—Urticaria—Zoledronate—osteoporosis	0.00125	0.00125	CcSEcCtD
Ceftazidime—Body temperature increased—Zoledronate—osteoporosis	0.00124	0.00124	CcSEcCtD
Ceftazidime—Abdominal pain—Zoledronate—osteoporosis	0.00124	0.00124	CcSEcCtD
Ceftazidime—Diarrhoea—Risedronate—osteoporosis	0.00124	0.00124	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00123	0.00123	CcSEcCtD
Ceftazidime—Dizziness—Ethinyl Estradiol—osteoporosis	0.00122	0.00122	CcSEcCtD
Ceftazidime—Pruritus—Pamidronate—osteoporosis	0.00121	0.00121	CcSEcCtD
Ceftazidime—Anaphylactic shock—Estradiol—osteoporosis	0.00121	0.00121	CcSEcCtD
Ceftazidime—Urticaria—Conjugated Estrogens—osteoporosis	0.0012	0.0012	CcSEcCtD
Ceftazidime—Dizziness—Risedronate—osteoporosis	0.00119	0.00119	CcSEcCtD
Ceftazidime—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00119	0.00119	CcSEcCtD
Ceftazidime—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00119	0.00119	CcSEcCtD
Ceftazidime—Nervous system disorder—Estradiol—osteoporosis	0.00118	0.00118	CcSEcCtD
Ceftazidime—Vomiting—Ethinyl Estradiol—osteoporosis	0.00118	0.00118	CcSEcCtD
Ceftazidime—Diarrhoea—Pamidronate—osteoporosis	0.00117	0.00117	CcSEcCtD
Ceftazidime—Skin disorder—Estradiol—osteoporosis	0.00117	0.00117	CcSEcCtD
Ceftazidime—Rash—Ethinyl Estradiol—osteoporosis	0.00117	0.00117	CcSEcCtD
Ceftazidime—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00117	0.00117	CcSEcCtD
Ceftazidime—Headache—Ethinyl Estradiol—osteoporosis	0.00116	0.00116	CcSEcCtD
Ceftazidime—Hypersensitivity—Zoledronate—osteoporosis	0.00115	0.00115	CcSEcCtD
Ceftazidime—Vomiting—Risedronate—osteoporosis	0.00115	0.00115	CcSEcCtD
Ceftazidime—Rash—Risedronate—osteoporosis	0.00114	0.00114	CcSEcCtD
Ceftazidime—Dermatitis—Risedronate—osteoporosis	0.00114	0.00114	CcSEcCtD
Ceftazidime—Dizziness—Pamidronate—osteoporosis	0.00113	0.00113	CcSEcCtD
Ceftazidime—Headache—Risedronate—osteoporosis	0.00113	0.00113	CcSEcCtD
Ceftazidime—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00111	0.00111	CcSEcCtD
Ceftazidime—Pruritus—Zoledronate—osteoporosis	0.00111	0.00111	CcSEcCtD
Ceftazidime—Nausea—Ethinyl Estradiol—osteoporosis	0.0011	0.0011	CcSEcCtD
Ceftazidime—Vomiting—Pamidronate—osteoporosis	0.00109	0.00109	CcSEcCtD
Ceftazidime—Paraesthesia—Estradiol—osteoporosis	0.00108	0.00108	CcSEcCtD
Ceftazidime—Rash—Pamidronate—osteoporosis	0.00108	0.00108	CcSEcCtD
Ceftazidime—Dermatitis—Pamidronate—osteoporosis	0.00108	0.00108	CcSEcCtD
Ceftazidime—Headache—Pamidronate—osteoporosis	0.00107	0.00107	CcSEcCtD
Ceftazidime—Diarrhoea—Zoledronate—osteoporosis	0.00107	0.00107	CcSEcCtD
Ceftazidime—Nausea—Risedronate—osteoporosis	0.00107	0.00107	CcSEcCtD
Ceftazidime—Pruritus—Conjugated Estrogens—osteoporosis	0.00107	0.00107	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Estradiol—osteoporosis	0.00104	0.00104	CcSEcCtD
Ceftazidime—Dizziness—Zoledronate—osteoporosis	0.00104	0.00104	CcSEcCtD
Ceftazidime—Pain—Estradiol—osteoporosis	0.00103	0.00103	CcSEcCtD
Ceftazidime—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00103	0.00103	CcSEcCtD
Ceftazidime—Nausea—Pamidronate—osteoporosis	0.00102	0.00102	CcSEcCtD
Ceftazidime—Dizziness—Conjugated Estrogens—osteoporosis	0.000998	0.000998	CcSEcCtD
Ceftazidime—Vomiting—Zoledronate—osteoporosis	0.000997	0.000997	CcSEcCtD
Ceftazidime—Rash—Zoledronate—osteoporosis	0.000988	0.000988	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Estradiol—osteoporosis	0.000988	0.000988	CcSEcCtD
Ceftazidime—Dermatitis—Zoledronate—osteoporosis	0.000987	0.000987	CcSEcCtD
Ceftazidime—Headache—Zoledronate—osteoporosis	0.000982	0.000982	CcSEcCtD
Ceftazidime—Vomiting—Conjugated Estrogens—osteoporosis	0.00096	0.00096	CcSEcCtD
Ceftazidime—Urticaria—Estradiol—osteoporosis	0.00096	0.00096	CcSEcCtD
Ceftazidime—Abdominal pain—Estradiol—osteoporosis	0.000955	0.000955	CcSEcCtD
Ceftazidime—Body temperature increased—Estradiol—osteoporosis	0.000955	0.000955	CcSEcCtD
Ceftazidime—Rash—Conjugated Estrogens—osteoporosis	0.000952	0.000952	CcSEcCtD
Ceftazidime—Dermatitis—Conjugated Estrogens—osteoporosis	0.000951	0.000951	CcSEcCtD
Ceftazidime—Headache—Conjugated Estrogens—osteoporosis	0.000945	0.000945	CcSEcCtD
Ceftazidime—Nausea—Zoledronate—osteoporosis	0.000931	0.000931	CcSEcCtD
Ceftazidime—Nausea—Conjugated Estrogens—osteoporosis	0.000896	0.000896	CcSEcCtD
Ceftazidime—Hypersensitivity—Estradiol—osteoporosis	0.00089	0.00089	CcSEcCtD
Ceftazidime—Pruritus—Estradiol—osteoporosis	0.000855	0.000855	CcSEcCtD
Ceftazidime—Diarrhoea—Estradiol—osteoporosis	0.000826	0.000826	CcSEcCtD
Ceftazidime—Dizziness—Estradiol—osteoporosis	0.000799	0.000799	CcSEcCtD
Ceftazidime—Vomiting—Estradiol—osteoporosis	0.000768	0.000768	CcSEcCtD
Ceftazidime—Rash—Estradiol—osteoporosis	0.000762	0.000762	CcSEcCtD
Ceftazidime—Dermatitis—Estradiol—osteoporosis	0.000761	0.000761	CcSEcCtD
Ceftazidime—Headache—Estradiol—osteoporosis	0.000757	0.000757	CcSEcCtD
Ceftazidime—Nausea—Estradiol—osteoporosis	0.000717	0.000717	CcSEcCtD
